Rayonier is rated a hold following its merger with PotlatchDeltic, reflecting cautious optimism due to its large, diverse timberland portfolio that offers long-term land appreciation potential. However, the company faces challenges with weak revenue and EBITDA margin trends, a high payout ratio, and a significant year-over-year decline in funds from operations, raising concerns about dividend safety and growth prospects. Despite undervaluation based on price/book and a solid investment-grade balance sheet supporting capital growth potential, market sentiment remains muted and integration risks persist, with no confirmed bullish technical trends yet.
YD Bio Limited's U.S. affiliate, EG BioMed US, has secured clinical lab licenses in Rhode Island and Pennsylvania, expanding its CLIA-certified, CAP-accredited lab's footprint to 46 states plus D.C. and Guam. This expansion enhances patient access to...
Vivani Medical's wholly owned subsidiary Cortigent will merge with Nasdaq-listed ClearOne, which will be renamed Cortigent Holdings and trade under the ticker CRGT. Vivani will own a majority stake in the combined company, which will focus on advanci...
Diffusion, a global communications agency, is growing its home and interiors portfolio by signing new clients including POVISON (furniture), LUSA Lighting, and Induction Hardware (appliances). The agency will support these premium brands with integra...
Heathrow Finance PLC announced a €350 million offering of 4-year senior secured notes with a stabilization period starting July 2, 2026, and ending by August 7, 2026. BNP Paribas and other major banks will manage the stabilization to support the bond...
Polibeli Group Ltd. has signed a non-binding Memorandum of Understanding with AUTHAIKAM COMPANY LIMITED to jointly evaluate a potential 100 MW AI computing center project in Thailand. The collaboration involves preliminary assessments such as site vi...
